tiprankstipranks
Trending News
More News >
Summit Therapeutics PLC (SMMT)
:SMMT
US Market

Summit Therapeutics (SMMT) Income Statement

Compare
1,835 Followers

Summit Therapeutics Income Statement

Last quarter (Q3 2025), Summit Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Summit Therapeutics's net income was $-231.79M. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 704.29K$ 1.81M$ 860.00K
Gross Profit
$ -15.01M$ -2.05M$ -1.81M$ 1.81M$ 860.00K
Operating Expenses
$ 211.30M$ 87.69M$ 64.28M$ 88.00M$ 53.19M
Depreciation and Amortization
$ 17.15M$ 155.32K$ 1.26M$ 2.46M$ 2.00M
EBITDA
$ -212.85M$ -69.45M$ -73.12M$ -85.91M$ -50.65M
Operating Income
$ 313.00K$ -89.74M$ -59.63M$ -86.19M$ -53.19M
Other Income/Expenses
$ -221.63M$ -526.14M$ -6.69M$ -2.42M$ 206.94K
Pretax Income
$ -221.31M$ -615.87M$ -78.78M$ -88.60M$ -52.91M
Net Income
$ -221.31M$ -614.93M$ -78.78M$ -88.60M$ -52.70M
Per Share Metrics
Basic EPS
$ -0.31$ -0.99$ -0.41$ -0.96$ -0.76
Diluted EPS
$ -0.31$ -0.99$ -0.38$ -0.96$ -0.76
Weighted Average Shares Outstanding
718.54M 619.65M 193.34M 92.24M 69.52M
Weighted Average Shares Outstanding (Diluted)
718.54M 619.65M 193.34M 92.24M 69.52M
Currency in USD

Summit Therapeutics Earnings and Revenue History